Literature DB >> 15877724

Gleason grading of prostate cancer in needle biopsies or radical prostatectomy specimens: contemporary approach, current clinical significance and sources of pathology discrepancies.

Rodolfo Montironi1, Roberta Mazzuccheli, Marina Scarpelli, Antonio Lopez-Beltran, Giovanni Fellegara, Ferran Algaba.   

Abstract

The Gleason grading system is a powerful tool to prognosticate and aid in the treatment of men with prostate cancer. The needle biopsy Gleason score correlates with virtually all other pathological variables, including tumour volume and margin status in radical prostatectomy specimens, serum prostate-specific antigen levels and many molecular markers. The Gleason score assigned to the tumour at radical prostatectomy is the most powerful predictor of progression after radical prostatectomy. However, there are significant deficiencies in the practice of this grading system. Not only are there problems among practising pathologists but also a relative lack of interobserver reproducibility among experts.

Entities:  

Mesh:

Year:  2005        PMID: 15877724     DOI: 10.1111/j.1464-410X.2005.05540.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  29 in total

Review 1.  Histopathology reporting of prostate needle biopsies. 2005 update.

Authors:  Rodolfo Montironi; Remigio Vela Navarrete; Antonio Lopez-Beltran; Roberta Mazzucchelli; Gregor Mikuz; Aldo V Bono
Journal:  Virchows Arch       Date:  2006-04-22       Impact factor: 4.064

Review 2.  Current practice of Gleason grading of prostate carcinoma.

Authors:  Antonio Lopez-Beltran; Gregor Mikuz; Rafael J Luque; Roberta Mazzucchelli; Rodolfo Montironi
Journal:  Virchows Arch       Date:  2005-11-23       Impact factor: 4.064

3.  Determination of the cutoff level of apparent diffusion coefficient values for detection of prostate cancer.

Authors:  Masako Nagayama; Yuji Watanabe; Akito Terai; Tohru Araki; Kenji Notohara; Akira Okumura; Yoshiki Amoh; Takayoshi Ishimori; Satoru Nakashita; Yoshihiro Dodo
Journal:  Jpn J Radiol       Date:  2011-09-01       Impact factor: 2.374

4.  Automated prostate tissue referencing for cancer detection and diagnosis.

Authors:  Jin Tae Kwak; Stephen M Hewitt; André Alexander Kajdacsy-Balla; Saurabh Sinha; Rohit Bhargava
Journal:  BMC Bioinformatics       Date:  2016-06-01       Impact factor: 3.169

5.  A high-throughput active contour scheme for segmentation of histopathological imagery.

Authors:  Jun Xu; Andrew Janowczyk; Sharat Chandran; Anant Madabhushi
Journal:  Med Image Anal       Date:  2011-04-28       Impact factor: 8.545

6.  Clinicopathological study of prostatic biopsies.

Authors:  A Josephine
Journal:  J Clin Diagn Res       Date:  2014-09-20

Review 7.  Reproducibility and reliability of tumor grading in urological neoplasms.

Authors:  Rainer Engers
Journal:  World J Urol       Date:  2007-09-09       Impact factor: 4.226

8.  [Histopathology reports of findings of prostate needle biopsies. Individual treatment].

Authors:  I Damjanoski; J Müller; T J Schnöller; R Küfer; L Rinnab
Journal:  Urologe A       Date:  2013-02       Impact factor: 0.639

9.  Prognostic implications of tissue and serum levels of microRNA-128 in human prostate cancer.

Authors:  Xiaoke Sun; Zhen Yang; Yu Zhang; Jing He; Feng Wang; Pengxiao Su; Juanli Han; Zhe Song; Yanjiang Fei
Journal:  Int J Clin Exp Pathol       Date:  2015-07-01

10.  Staphylococcal nuclease domain-containing protein 1 as a potential tissue marker for prostate cancer.

Authors:  Hidetoshi Kuruma; Yuko Kamata; Hiroyuki Takahashi; Koji Igarashi; Takahiro Kimura; Kenta Miki; Jun Miki; Hiroshi Sasaki; Norihiro Hayashi; Shin Egawa
Journal:  Am J Pathol       Date:  2009-05-12       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.